Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail
Código 300310 (Harmonized System 2012 by 6 digits)
Código 300310 (Harmonized System 2012 by 6 digits)
The RCA-Complexity diagram compares the Revelead Comparative Advantages of states in Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail and the Economic Complexity Index of each state.
RCA values greater than 1 indicate that the state has comparative advantages in Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail. On the other hand, high levels of complexity (ECI) are associated with higher levels of income, potential for economic growth, lower income inequality and lower emissions.
The visualizations show the global market for Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail. In both charts, Mexico stands out in order to identify its participation in the export and import market.
In 2022, the main exporting countries of Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were N/A. In the same year, the main importing countries for Medicaments Containing Penicillins or Derivatives Thereof with the Structure of Penicillanic Acid or Streptomycins or Derivatives Thereof, not in Measured Doses or put up for Sale to the Retail were N/A.